# FDA Inspection 1053161 - ABO Holdings Inc - April 26, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/abo-holdings-inc/fb226e5b-6e9e-4da0-a96e-f9894b65266e/
Source feed: FDA_Inspections

> FDA Inspection 1053161 for ABO Holdings Inc on April 26, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1053161
- Company Name: ABO Holdings Inc
- Inspection Date: 2018-04-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1258956 - 2024-12-11](https://www.globalkeysolutions.net/api/records/fda_inspections/abo-holdings-inc/99e4fb33-c9e2-41d3-8926-9a1e5035aecb/)
- [FDA Inspection 1258956 - 2024-12-11](https://www.globalkeysolutions.net/api/records/fda_inspections/abo-holdings-inc/48f3fbfb-cc49-4b84-9f3b-f49c06fcbe19/)
- [FDA Inspection 956451 - 2015-12-21](https://www.globalkeysolutions.net/api/records/fda_inspections/abo-holdings-inc/8ecfaf06-74c3-4fa5-aa63-81151dacf523/)

Company: https://www.globalkeysolutions.net/companies/abo-holdings-inc/fc176857-600d-4db5-9948-b24874bb5499

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d